E2F7 and E2F8 have been reported to be involved in several malignancies such as pancreatic cancer (61), gallbladder cancer (62), colorectal cancer (63, 64), cervical cancer (65), breast cancer (66) and lung cancer (67, 68). Here, E2F8 is linked to breast carcinoma.